» Articles » PMID: 19575687

The Relationship Between Gravidity and Parity and Colorectal Cancer Risk

Overview
Date 2009 Jul 7
PMID 19575687
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The influence of hormonal changes caused by pregnancy has been well studied in relation to colorectal cancer risk, but the association remains undefined. The purpose of this investigation was to examine in a case-control study the relationship between differences in gravidity and parity and colorectal cancer risk and if the association varied by microsatellite instability (MSI), a feature more common in women.

Methods: The study population included incident colorectal cancer patients (n = 1014), aged 50-74 years, diagnosed in 1998-2002 in Washington state and controls (n = 1064) randomly selected from population lists. All study subjects completed telephone interviews to ascertain prior pregnancies, live births, and other covariates. Case tissue samples were obtained for MSI analyses. Multivariable logistic regression models estimated odds ratios (OR) and 95% confidence intervals (CI), adjusting for age, family history of colorectal cancer, body mass index (BMI), education, endoscopy screening, oral contraceptive use, hormone therapy use, smoking, and alcohol consumption.

Results: There was an approximate 30%-50% reduction in risk of colon cancer associated with gravidity, which was attenuated in the analysis with parity. Increasing gravidity and parity were associated with a suggestion of a decreasing trend in risk for rectal cancer (p for trend = 0.07). Compared with women who had equal numbers of pregnancies and live births, women who were nulligravid and nulliparous had a 40%-60% increased risk of colon cancer. There was a suggestion of a reduced risk of both colon and rectal cancer associated with one more pregnancy than live birth. There was a suggestion of an increased risk of MSI-high tumors with nulligravidity and nulliparity.

Conclusions: These results confirm the importance of pregnancy events in the etiology of colon and rectal cancer.

Citing Articles

Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants.

Cramer D, Vitonis A, Fichorova R, Yamamoto H, Mudugno F, Finn O Cancer Epidemiol Biomarkers Prev. 2024; 33(9):1211-1219.

PMID: 38864844 PMC: 11371522. DOI: 10.1158/1055-9965.EPI-24-0187.


Predictors of CRC Stage at Diagnosis among Male and Female Adults Participating in a Prospective Cohort Study: Findings from Alberta's Tomorrow Project.

Ghebrial M, Aktary M, Wang Q, Spinelli J, Shack L, Robson P Curr Oncol. 2021; 28(6):4938-4952.

PMID: 34898587 PMC: 8628758. DOI: 10.3390/curroncol28060414.


Risk factors for early-onset colorectal cancer: a population-based case-control study in Ontario, Canada.

Chang V, Cotterchio M, De P, Tinmouth J Cancer Causes Control. 2021; 32(10):1063-1083.

PMID: 34120288 PMC: 8416813. DOI: 10.1007/s10552-021-01456-8.


Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer.

Williams W, Mitchell L, Carlson S, Raviele K Linacre Q. 2020; 85(4):412-452.

PMID: 32431377 PMC: 6322132. DOI: 10.1177/0024363918811637.


Gallbladder diseases in pregnancy: Sonographic findings in an indigenous African population.

Idowu B, Onigbinde S, Ebie I, Adeyemi M J Ultrason. 2020; 19(79):269-275.

PMID: 32021708 PMC: 6988454. DOI: 10.15557/JoU.2019.0040.


References
1.
Boland C, Thibodeau S, Hamilton S, Sidransky D, Eshleman J, Burt R . A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58(22):5248-57. View

2.
Wood A, Thomas C, Baumforth K, Flavell J, SCOTT K, Grace R . Absence of prolactin gene expression in colorectal cancer. Mol Pathol. 2000; 52(3):135-9. PMC: 395687. DOI: 10.1136/mp.52.3.135. View

3.
Patel D, Bhatavdekar J, Ghosh N, Vora H, Karelia N, Shah N . Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator. Cancer. 1994; 73(3):570-4. DOI: 10.1002/1097-0142(19940201)73:3<570::aid-cncr2820730312>3.0.co;2-i. View

4.
Musey V, Collins D, Musey P, PREEDY J . Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med. 1987; 316(5):229-34. DOI: 10.1056/NEJM198701293160501. View

5.
Martinez M, Grodstein F, Giovannucci E, Colditz G, Speizer F, Hennekens C . A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1997; 6(1):1-5. View